Low frequency of pre-treatment and post-treatment haematological abnormalities in dogs with non-infectious meningoencephalitis treated with cytosine arabinoside and prednisolone

BackgroundCytosine arabinoside (CA) and prednisolone are drugs commonly used together in the management of canine non-infectious meningoencephalitis (NIME). The aim of this study was to report the haematological findings before and after CA and prednisolone treatment and identify any adverse haemato...

Full description

Saved in:
Bibliographic Details
Published inVeterinary record open Vol. 6; no. 1; pp. e000315 - n/a
Main Authors Keegan, Sarah, Rose, Jeremy H, Khan, Zohra, Liebel, Francois-Xavier
Format Journal Article
LanguageEnglish
Published United States British Veterinary Association 01.01.2019
Blackwell Publishing Ltd
BMJ Publishing Group
SeriesResearch
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundCytosine arabinoside (CA) and prednisolone are drugs commonly used together in the management of canine non-infectious meningoencephalitis (NIME). The aim of this study was to report the haematological findings before and after CA and prednisolone treatment and identify any adverse haematological events in this clinical setting, following the veterinary cooperative oncology group established common terminology criteria for recording adverse events following administration of chemotherapy or biological antineoplastic therapy.ResultsWhile 48 patients with a presumptive diagnosis of NIME had pretreatment haematology results, only 12 patients met the inclusion criteria of also having post-treatment haematology results available for review after being treated with prednisolone and CA at a standard dose (200 mg/m2) in a single referral hospital in the UK. Forty-nine post-treatment haematology results were available for these 12 patients.ConclusionsFour adverse haematological events were identified in four patients. None of these events were convincingly attributable to CA administration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2052-6113
2399-2050
2052-6113
DOI:10.1136/vetreco-2018-000315